Farouc A Jaffer Selected Research

Myocardial Infarction

1/2022	Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
1/2022	Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.
1/2022	Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
12/2021	Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention.
9/2021	Procedural and In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction: Insights From a Prospective Multicenter International Registry.
1/2021	In-Stent CTO Percutaneous Coronary Intervention: Individual Patient Data Pooled Analysis of 4 Multicenter Registries.
12/2020	Technical and procedural outcomes of the retrograde approach to chronic total occlusion interventions.
11/2020	Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes.
1/2019	Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions.
1/2019	Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Farouc A Jaffer Research Topics

Disease

30	Atherosclerosis 01/2022 - 03/2004
28	Thrombosis (Thrombus) 01/2022 - 03/2002
18	Inflammation (Inflammations) 10/2021 - 10/2006
17	Myocardial Infarction 01/2022 - 03/2006
15	Atherosclerotic Plaque (Atheroma) 01/2022 - 03/2006
12	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 03/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2013
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 08/2011
6	Diabetes Mellitus 01/2022 - 11/2015
6	Stroke (Strokes) 01/2022 - 04/2017
6	Heart Failure 11/2020 - 03/2004
5	Hemorrhage 01/2022 - 10/2013
4	Rupture 01/2022 - 11/2010
4	Peripheral Arterial Disease 01/2022 - 04/2017
3	Neointima 10/2021 - 06/2013
3	Cicatrix (Scar) 01/2021 - 03/2006
3	Hypertension (High Blood Pressure) 11/2020 - 04/2017
3	Vascular System Injuries 11/2017 - 06/2011
2	Cardiogenic Shock 01/2022 - 01/2019
2	Death (Near-Death Experience) 01/2022 - 10/2020
2	Arteritis 10/2021 - 06/2011
2	Postthrombotic Syndrome 01/2021 - 01/2021
2	ST Elevation Myocardial Infarction 01/2021 - 01/2021
2	Dyslipidemias (Dyslipidemia) 11/2020 - 04/2017
2	Pathologic Constriction (Stenosis) 02/2020 - 06/2017
2	Disease Progression 01/2019 - 04/2009
2	Chronic Renal Insufficiency 11/2018 - 04/2009
2	Thoracic Aortic Aneurysm 01/2018 - 01/2018
2	Aneurysm (Aneurysms) 01/2018 - 01/2018
2	Carotid Artery Diseases 01/2016 - 10/2010
2	Infarction (Infarctions) 02/2008 - 12/2006
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Coronary Occlusion 01/2022
1	Hyperplasia 10/2021
1	Vascular Diseases (Vascular Disease) 10/2021
1	Venous Insufficiency 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Atrial Fibrillation 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Fatigue 01/2021
1	COVID-19 01/2021
1	Acute Coronary Syndrome 10/2020
1	Arteriovenous Fistula 01/2020
1	Fistula 01/2020

Drug/Important Bio-Agent (IBA)

11	FibrinIBA 01/2022 - 01/2012
10	LipidsIBA 01/2022 - 11/2010
9	Biological ProductsIBA 01/2017 - 04/2006
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2017
5	CholesterolIBA 01/2022 - 10/2010
5	ApolipoproteinsIBA 10/2010 - 04/2006
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 03/2006
4	CollagenIBA 01/2015 - 02/2008
4	Peptide Hydrolases (Proteases)FDA Link 08/2011 - 04/2006
4	Cysteine Proteases (Cysteine Protease)IBA 08/2011 - 05/2007
3	MetalsIBA 10/2021 - 06/2011
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2015
3	Pharmaceutical PreparationsIBA 07/2020 - 12/2013
3	Matrix Metalloproteinases (MMPs)IBA 11/2013 - 10/2010
3	Fluorescent Dyes (Fluorescent Probes)IBA 08/2011 - 11/2002
2	CeroidIBA 01/2022 - 01/2021
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2021 - 03/2006
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2015
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 01/2015
2	Contractile ProteinsIBA 01/2018 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 06/2015
2	Cell Adhesion MoleculesIBA 01/2017 - 01/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2015 - 07/2012
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2015 - 01/2012
2	Factor XIIIaIBA 07/2012 - 07/2004
2	Dextrans (Dextran)FDA Link 07/2012 - 04/2006
2	TransglutaminasesIBA 02/2008 - 12/2006
2	Serine Proteases (Serine Protease)IBA 11/2002 - 03/2002
2	Thrombin FDA Link 11/2002 - 03/2002
1	Glycophorins (Glycophorin C)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021
1	CalponinsIBA 10/2021
1	Differentiation AntigensIBA 10/2021
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 07/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2020
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 02/2020
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 02/2020

Therapy/Procedure

17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 11/2015
15	Stents 09/2022 - 11/2010
15	Therapeutics 01/2021 - 03/2006
13	Catheters 01/2022 - 10/2008
8	Percutaneous Coronary Intervention 09/2022 - 11/2016
2	Carotid Endarterectomy 01/2022 - 05/2007
2	Thrombolytic Therapy 01/2015 - 07/2012
2	Precision Medicine 07/2012 - 09/2010
2	Lasers (Laser) 02/2011 - 03/2006
2	Drug Therapy (Chemotherapy) 11/2008 - 10/2006
1	Thrombectomy 01/2022
1	Sutures (Suture) 04/2020
1	Immunomodulation 02/2020